Avecho Biotechnology Limited Cash Flow Conversion Efficiency

Latest as of December 2022: -0.334x

Avecho Biotechnology Limited cash flow conversion efficiency. Based on the latest financial reports, Avecho Biotechnology Limited (OEZ) has a cash flow conversion efficiency ratio of -0.334x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-808.80K ≈ $-945.58K USD) by net assets (€2.42 Million ≈ $2.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Avecho Biotechnology Limited (2013–2022)

Cash flow conversion efficiency of Avecho Biotechnology Limited from 2013 to 2022. This chart illustrates how Avecho Biotechnology Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View OEZ share price today for real-time trading data and today's change.

Avecho Biotechnology Limited Cash Flow Conversion Ratio Explained

Avecho Biotechnology Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Avecho Biotechnology Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Avecho Biotechnology Limited ranked by their cash flow conversion efficiency. Also see Avecho Biotechnology Limited market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Country Group Development Public Company Limited BK:CGD	-0.015x
Valbiotis SAS PA:ALVAL	-0.592x
Lotus KFM Bhd KLSE:8303	0.005x
Seoyon Topmetal Co. Ltd KQ:019770	0.081x
Teaminvest Private Group Ltd AU:TIP	0.063x
Higher Way Electronic Co Ltd TWO:3268	-0.040x
Terranet AB ST:TERRNT-B	-0.177x
Galil Capital Re Spain SOCIMI SA MC:YGCS	-0.034x

Annual Cash Flow Conversion Efficiency for Avecho Biotechnology Limited (2013–2022)

The table below shows the annual cash flow conversion efficiency of Avecho Biotechnology Limited from 2013 to 2022. Review OEZ cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	€2.42 Million ≈ $2.83 Million	€-1.67 Million ≈ $-1.95 Million	-0.687x	-0.54%
2021-12-31	€4.54 Million ≈ $5.30 Million	€-3.10 Million ≈ $-3.62 Million	-0.683x	-27.33%
2020-12-31	€2.65 Million ≈ $3.10 Million	€-1.42 Million ≈ $-1.66 Million	-0.536x	-316.76%
2019-12-31	€4.76 Million ≈ $5.56 Million	€1.18 Million ≈ $1.38 Million	0.247x	+144.12%
2018-12-31	€3.90 Million ≈ $4.56 Million	€-2.19 Million ≈ $-2.56 Million	-0.561x	+44.06%
2017-12-31	€6.40 Million ≈ $7.49 Million	€-6.42 Million ≈ $-7.51 Million	-1.003x	-82.13%
2016-12-31	€11.65 Million ≈ $13.62 Million	€-6.41 Million ≈ $-7.50 Million	-0.551x	-82.96%
2015-12-31	€28.93 Million ≈ $33.82 Million	€-8.71 Million ≈ $-10.18 Million	-0.301x	-118.93%
2014-12-31	€49.03 Million ≈ $57.32 Million	€-6.74 Million ≈ $-7.88 Million	-0.137x	+36.70%
2013-12-31	€39.50 Million ≈ $46.18 Million	€-8.58 Million ≈ $-10.03 Million	-0.217x	--

About Avecho Biotechnology Limited

F:OEZ Germany Biotechnology

Market Cap

$30.12 Million

€25.76 Million EUR

Market Cap Rank

#24129 Global

#2089 in Germany

Share Price

€0.01

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.01

All Time High

€0.03